Preferred Label : azepines;
MeSH definition : Seven membered heterocyclic rings containing a NITROGEN atom.;
MeSH synonym : hexamethyleneimines;
Wikipedia link : https://en.wikipedia.org/wiki/Azepines;
Is substance : O;
Origin ID : D001381;
UMLS CUI : C0004484;
Allowable qualifiers
Record concept(s)
Related MeSH Supplementary Concept(s)
- (3aR,8aR)-2,2-dimethyl-4,4,8,8-tetraphenyl-4,5,6,7,8,8a-hexahydro-3aH-1,3-dioxolo(4,5-e)(1,3)diazepin-6-one [MeSH Supplementary Concept]
- 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta(b)(1,4)diazepino(6,7,1hj)indole [MeSH Supplementary Concept]
- 1,2,7,8,9,10,11,13-octahydro-4-(3-hydroxyphenylthio)-13-oxo-(1)benzothieno-(2',3'-4,5)pyrimido(1,2-a)azepine-3-carboxaldehyde [MeSH Supplementary Concept]
- 1-phenyl-3,5,8-trimethyl-1,4,5,6,7,8-hexahydropyrazolo(3,4-e)(1,4)diazepin-4,7-dione [MeSH Supplementary Concept]
- 2,3,4,5,5a,6,7,7a,7b,8,9,9a,10,11,12,13,13a,15,15a,15b-eicosahydro-5,5,7a,7b,9a,12,15b-heptamethyl-3,15-dioxo-N-hydroxy-N-methyl-1H-chryseno(2,1-c)azepine-12-carboxylic
acid amide [MeSH Supplementary Concept]
- 6-(2-chlorophenyl)-3-(4-(6-ethoxycarbonyl-1-(3-pyridyl)-1-hexenyl)phenyllmethyl)-8,11-dimethyl-2,3,4,5-tetrahydro-8H-pyrido(4',3'-4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)diazepine [MeSH Supplementary Concept]
- ARV-825 [MeSH Supplementary Concept]
- AS-9705 [MeSH Supplementary Concept]
- ASP2205 [MeSH Supplementary Concept]
- AZ1136 [MeSH Supplementary Concept]
- BK 129 [MeSH Supplementary Concept]
- BQ 485 [MeSH Supplementary Concept]
- CI 1044 [MeSH Supplementary Concept]
- CM304 [MeSH Supplementary Concept]
- CPI203 [MeSH Supplementary Concept]
- CSN5i-3 [MeSH Supplementary Concept]
- CX-6258 [MeSH Supplementary Concept]
- DAT 582 [MeSH Supplementary Concept]
- DDD-028 [MeSH Supplementary Concept]
- DMP 323 [MeSH Supplementary Concept]
- DMP 450 [MeSH Supplementary Concept]
- E 6123 [MeSH Supplementary Concept]
- FA-103 [MeSH Supplementary Concept]
- HOE 175 [MeSH Supplementary Concept]
- IBE-667 [MeSH Supplementary Concept]
- IN6CPBD [MeSH Supplementary Concept]
- IVDE77 [MeSH Supplementary Concept]
- K 11430 [MeSH Supplementary Concept]
- K 7174 [MeSH Supplementary Concept]
- LR 1143 [MeSH Supplementary Concept]
- MELK-T1 [MeSH Supplementary Concept]
- MK 2918 [MeSH Supplementary Concept]
- ML 7 [MeSH Supplementary Concept]
- ML 9 [MeSH Supplementary Concept]
- PPO 464 [MeSH Supplementary Concept]
- RO3280 [MeSH Supplementary Concept]
- SD 894 [MeSH Supplementary Concept]
- SI-591 [MeSH Supplementary Concept]
- SX 810 [MeSH Supplementary Concept]
- U 92798 [MeSH Supplementary Concept]
- VLX1570 [MeSH Supplementary Concept]
- XK 263 [MeSH Supplementary Concept]
- XM 323 [MeSH Supplementary Concept]
- we 1008 [MeSH Supplementary Concept]
See also
Semantic type(s)
Seven membered heterocyclic rings containing a NITROGEN atom.
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00431
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
suvorexant
suvorexant
suvorexant
administration, oral
sleep initiation and maintenance disorders
Orexin Receptor Antagonists
Orexin Receptor Antagonists
azepines
triazoles
azepines
triazoles
---
http://www.lecrat.eu/?s=Clotiaz%C3%A9pam+-+VERATRAN%C2%AE
2008
France
French
azepines
pregnancy
anti-anxiety agents
infant, newborn
clotiazepam
clotiazepam
drug information
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3194_veratran_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_486484
2007
France
French
clotiazepam
anti-anxiety agents
administration, oral
azepines
clotiazepam
insurance, health, reimbursement
anxiety disorders
alcohol withdrawal delirium
alcohol withdrawal delirium
tablets
azepines
evaluation of the transparency committee
---